Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Cayman Islands.
Press releases published on July 15, 2025
Coralogix Introduces MCP Server to Help Customers Build Smarter AI Agents
GlobeNewswire
·
July 15, 2025
BOSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Coralogix, a leading full-stack observability platform provider, today unveiled the official Coralogix MCP (Model Context Protocol) Server, which enables third-party AI agents to connect directly to Coralogix’s …
Cycurion (NASDAQ: CYCU) Launches “Cycurion Crypto” Subsidiary with $10 Million Treasury Allocation to Acquire Ethereum and Bitcoin
GlobeNewswire
·
July 15, 2025
MCLEAN, Va., July 15, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion”), a leading cybersecurity and digital infrastructure company, today announced the formation of a wholly owned subsidiary, Cycurion Crypto, as part of its strategic …
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
GlobeNewswire
·
July 15, 2025
BOSTON and KANSAS CITY, Kan., July 15, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development …
New report: Generative AI use doubles while trust in social media plummets
GlobeNewswire
·
July 15, 2025
CIRA’s 2025 Internet Trends Report reveals how trust, innovation and tariffs are reshaping Canada’s digital landscape OTTAWA, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- As Canadians navigate economic uncertainty and rapid technological change, they are …
Research: Consumer Mobile Frustration Is Rising – And It’s Costing Brands
GlobeNewswire
·
July 15, 2025
ATLANTA, July 15, 2025 (GLOBE NEWSWIRE) -- Fullstory, a leading behavioral data company, today unveiled findings from its 2025 Behavioral Insights Benchmark Report, analyzing year-over-year trends in user digital experience across platforms. This year’s …
Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01
GlobeNewswire
·
July 15, 2025
Dr. Lotan’s distinguished expertise in bladder cancer care and clinical development brings further scientific acumen to Relmada’s NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- …
Xsolis Launches AI Amplified, a New Podcast Hosted by Chief Medical Officer Dr. Heather Bassett, Spotlighting the Real-World Impact of AI in Healthcare
GlobeNewswire
·
July 15, 2025
FRANKLIN, Tenn., July 15, 2025 (GLOBE NEWSWIRE) -- Xsolis, an AI-driven healthcare technology company that reduces administrative waste by enabling collaboration between healthcare providers and payers, today announced the launch of AI Amplified, a new …
ZenaTech to Accelerate ZenaDrone Manufacturing for US Defense and Commercial Drones Following Recent One Big Beautiful Bill, Executive Orders, and Secretary of Defense Policy Directives
GlobeNewswire
·
July 15, 2025
VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
American Rebel Holdings, Inc. (NASDAQ:AREB) Announces Record-Breaking Launch of American Rebel Light Beer in Mississippi with Clark Beverage Group
GlobeNewswire
·
July 15, 2025
Rebel Light Beer Ignites Mississippi with Largest-Ever Opening Order, Fueling Continued National Expansion of America’s Patriotic Beer NASHVILLE, TN, July 15, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB), the proud creator of …
UPCX Staking Surpasses 975,000 Tokens as Web3 Payment Ecosystem Accelerates Expansion
GlobeNewswire
·
July 15, 2025
Singapore, July 15, 2025 (GLOBE NEWSWIRE) -- UPCX is a blockchain-based open-source payment platform dedicated to providing secure, transparent, and compliant financial services to users worldwide. Since the launch of its mainnet in October 2024, the UPCX …
PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market
GlobeNewswire
·
July 15, 2025
PolyPid's proprietary and clinically validated, prolonged-release drug delivery technology aims to subcutaneously deliver GLP-1 for approximately 60 days, compared to current standard of care of weekly injections. The GLP-1 delivery platform expands …
A State Department of Transportation (DOT) Has Entered Into A Formal Contractual Agreement To Evaluate ProStar’s PointMan
GlobeNewswire
·
July 15, 2025
GRAND JUNCTION, Colo., July 15, 2025 (GLOBE NEWSWIRE) -- ProStar Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), a world leader in Precision Mapping Solutions®, is pleased to announce that a State Department of …
Neo Pepe Coin ($NEOP) Announces Massive Giveaway, Rewarding Early Community Members
GlobeNewswire
·
July 15, 2025
A Generous Initiative for Loyal Supporters ROAD TOWN, British Virgin Islands, July 15, 2025 (GLOBE NEWSWIRE) -- Neo Pepe Coin ($NEOP), one of this year's standout memecoins, has officially launched an expansive and exciting giveaway program. This generous …
SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study
GlobeNewswire
·
July 15, 2025
The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW) and 50% in AML MR with …
Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
GlobeNewswire
·
July 15, 2025
– Mean weight loss of 19.2% at 6 mg with no plateau in 48-week Phase 3 trial – – Favorable safety profile consistent with other GLP-1-based treatments – – Hengrui to submit NDA in China; Kailera plans to evaluate both higher doses and longer duration of …
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
GlobeNewswire
·
July 15, 2025
SAN CARLOS, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
GlobeNewswire
·
July 15, 2025
- Lucile Packard Children’s Hospital Stanford is ready to accept patients for ZEVASKYN treatment - - Abeona Therapeutics® and Stanford Medicine conducted research collaboration for more than a decade, culminating in U.S. Food and Drug Administration (FDA) …
BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer
GlobeNewswire
·
July 15, 2025
PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to …
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
GlobeNewswire
·
July 15, 2025
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetes FDA also confirmed that the ongoing Phase 3 PROACT 1 study can be used for both accelerated approval and for …
Neuronetics Appoints New Chief Financial Officer
GlobeNewswire
·
July 15, 2025
Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession process Neuronetics reiterates guidance for second …